CN115466185A - A kind of preparation method of 6PPD metabolite - Google Patents
A kind of preparation method of 6PPD metabolite Download PDFInfo
- Publication number
- CN115466185A CN115466185A CN202211129168.3A CN202211129168A CN115466185A CN 115466185 A CN115466185 A CN 115466185A CN 202211129168 A CN202211129168 A CN 202211129168A CN 115466185 A CN115466185 A CN 115466185A
- Authority
- CN
- China
- Prior art keywords
- 6ppd
- preparation
- reductive amination
- metabolite
- amination reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002207 metabolite Substances 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Chemical compound CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 claims abstract description 26
- 238000006268 reductive amination reaction Methods 0.000 claims abstract description 26
- 239000003960 organic solvent Substances 0.000 claims abstract description 17
- ATGUVEKSASEFFO-UHFFFAOYSA-N p-aminodiphenylamine Chemical compound C1=CC(N)=CC=C1NC1=CC=CC=C1 ATGUVEKSASEFFO-UHFFFAOYSA-N 0.000 claims abstract description 17
- 238000006243 chemical reaction Methods 0.000 claims abstract description 15
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 13
- 238000005984 hydrogenation reaction Methods 0.000 claims abstract description 13
- 238000002156 mixing Methods 0.000 claims abstract description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical group CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 46
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- 238000004440 column chromatography Methods 0.000 claims description 11
- 239000012074 organic phase Substances 0.000 claims description 10
- 239000003208 petroleum Substances 0.000 claims description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 238000003818 flash chromatography Methods 0.000 claims description 6
- -1 sodium triacetoxyborohydride Chemical compound 0.000 claims description 6
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 claims description 5
- 239000012279 sodium borohydride Substances 0.000 claims description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 4
- 239000012321 sodium triacetoxyborohydride Substances 0.000 claims description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 4
- 239000003480 eluent Substances 0.000 claims description 3
- 239000012046 mixed solvent Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 238000009776 industrial production Methods 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract description 4
- 230000002503 metabolic effect Effects 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 239000013558 reference substance Substances 0.000 abstract description 4
- 230000009897 systematic effect Effects 0.000 abstract description 4
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 238000012502 risk assessment Methods 0.000 abstract description 3
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 238000009510 drug design Methods 0.000 abstract description 2
- 230000036267 drug metabolism Effects 0.000 abstract description 2
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 15
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 4
- 238000007865 diluting Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- ZZMVLMVFYMGSMY-UHFFFAOYSA-N 4-n-(4-methylpentan-2-yl)-1-n-phenylbenzene-1,4-diamine Chemical compound C1=CC(NC(C)CC(C)C)=CC=C1NC1=CC=CC=C1 ZZMVLMVFYMGSMY-UHFFFAOYSA-N 0.000 description 2
- ARTUPXOMMHDISM-UHFFFAOYSA-N CC(CC(C)(C)O)NC(C=C1)=CC=C1NC1=CC=CC=C1 Chemical compound CC(CC(C)(C)O)NC(C=C1)=CC=C1NC1=CC=CC=C1 ARTUPXOMMHDISM-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000005292 vacuum distillation Methods 0.000 description 2
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- YKIOKAURTKXMSB-UHFFFAOYSA-N adams's catalyst Chemical compound O=[Pt]=O YKIOKAURTKXMSB-UHFFFAOYSA-N 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 239000005061 synthetic rubber Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明涉及药物代谢技术领域,具体涉及一种6PPD代谢物的制备方法。本发明提供的制备方法,包括以下步骤:将4‑氨基二苯胺、二丙酮醇、有机溶剂和氢化试剂混合进行还原胺化反应,得到式I所示结构的6PPD代谢物。本发明提供的制备方法以4‑氨基二苯胺、二丙酮醇和氢化试剂为原料,通过合理设计反应合成路线:通过一步法进行还原胺化反应,实现了6PPD代谢物成功制备,且得率高,可为6PPD的代谢机理研究提供对照品,可用于研究该药物在环境中的代谢过程,对6PPD及其代谢物的系统性研究及风险评估具有极大的价值。且本发明提供的制备方法制备成本低、可操作性强,安全系数高,可实现工业化生产。
The invention relates to the technical field of drug metabolism, in particular to a preparation method of 6PPD metabolites. The preparation method provided by the present invention comprises the following steps: mixing 4-aminodiphenylamine, diacetone alcohol, an organic solvent and a hydrogenation reagent to carry out reductive amination reaction to obtain the 6PPD metabolite with the structure shown in formula I. The preparation method provided by the invention uses 4-aminodiphenylamine, diacetone alcohol and hydrogenation reagent as raw materials, and through rational design of the reaction synthesis route: through a one-step reductive amination reaction, the successful preparation of 6PPD metabolites is achieved, and the yield is high. It can provide a reference substance for the study of the metabolic mechanism of 6PPD, and can be used to study the metabolic process of the drug in the environment. It is of great value for the systematic research and risk assessment of 6PPD and its metabolites. Moreover, the preparation method provided by the invention has low preparation cost, strong operability, high safety factor, and can realize industrial production.
Description
技术领域technical field
本发明涉及药物代谢技术领域,尤其涉及一种6PPD代谢物的制备方法。The invention relates to the technical field of drug metabolism, in particular to a preparation method of 6PPD metabolites.
背景技术Background technique
6PPD,即N-(1,3-二甲基丁基)-N'-苯基对苯二胺,CAS号为793-24-8,是一种常用的抗臭氧剂,具有优良的抗氧、抗臭氧、抗曲挠龟裂等作用,适用于各类合成橡胶和天然橡胶,也可作为聚乙烯、聚丙烯、丙烯酸树脂的热氧稳定剂。6PPD, N-(1,3-dimethylbutyl)-N'-phenyl-p-phenylenediamine, CAS No. 793-24-8, is a commonly used antiozonant with excellent antioxidant properties , anti-ozone, anti-flex cracking, etc., suitable for all kinds of synthetic rubber and natural rubber, and can also be used as a thermal oxygen stabilizer for polyethylene, polypropylene, and acrylic resins.
6PPD在大鼠中的主要代谢产物为2-甲基-4-((4-(苯基氨基)苯基)氨基)戊烷-2-醇,化学结构式如式I所示。目前缺少6PPD代谢物的环境行为及毒性等数据,美国专利US3388096A公开的式1所示结构的制备过程中,需要使用亚当斯催化剂(PtO2),制作成本高且制备方法危险系数高,为6PPD代谢物的系统性研究带来困难,影响6PPD风险评估的准确性。The main metabolite of 6PPD in rats is 2-methyl-4-((4-(phenylamino)phenyl)amino)pentan-2-ol, the chemical structure of which is shown in Formula I. At present, there is a lack of data on the environmental behavior and toxicity of 6PPD metabolites. In the preparation process of the structure shown in formula 1 disclosed in US Patent US3388096A, Adams catalyst (PtO 2 ) needs to be used. Systematic research on drugs brings difficulties and affects the accuracy of 6PPD risk assessment.
发明内容Contents of the invention
本发明的目的在于提供一种6PPD代谢物的制备方法,本发明提供的制备方法成本低,且制备得到的6PPD代谢物得率高,可操作性强,适宜工业化生产。The object of the present invention is to provide a method for preparing 6PPD metabolites. The preparation method provided by the present invention has low cost, and the prepared 6PPD metabolites have high yield, strong operability, and are suitable for industrial production.
为了实现上述目的,本发明提供如下技术方案:In order to achieve the above object, the present invention provides the following technical solutions:
本发明提供了一种6PPD代谢物的制备方法,包括以下步骤:The present invention provides a kind of preparation method of 6PPD metabolite, comprises the following steps:
将4-氨基二苯胺、二丙酮醇、有机溶剂和氢化试剂混合进行还原胺化反应,得到式I所示结构的6PPD代谢物;4-aminodiphenylamine, diacetone alcohol, an organic solvent and a hydrogenation reagent are mixed for reductive amination reaction to obtain the 6PPD metabolite of the structure shown in formula I;
优选的,所述氢化试剂包括硼氢化钠、氰基硼氢化钠和三乙酰氧基硼氢化钠中的一种或多种。Preferably, the hydrogenation reagent includes one or more of sodium borohydride, sodium cyanoborohydride and sodium triacetoxyborohydride.
优选的,所述氢化试剂和所述4-氨基二苯胺的摩尔比为(1~2):1。Preferably, the molar ratio of the hydrogenation reagent to the 4-aminodiphenylamine is (1-2):1.
优选的,所述二丙酮醇和所述4-氨基二苯胺的摩尔比为(1~2):1。Preferably, the molar ratio of the diacetone alcohol to the 4-aminodiphenylamine is (1-2):1.
优选的,所述还原胺化反应的温度为10~40℃,所述还原胺反应的保温时间为8~24h。Preferably, the temperature of the reductive amination reaction is 10-40° C., and the holding time of the reductive amine reaction is 8-24 hours.
优选的,所述有机溶剂包括四氢呋喃、甲醇或二氯甲烷。Preferably, the organic solvent includes tetrahydrofuran, methanol or dichloromethane.
优选的,所述还原胺化反应后直接得到还原胺化反应液,还包括以下步骤:Preferably, the reductive amination reaction solution is directly obtained after the reductive amination reaction, further comprising the following steps:
将所述还原胺化反应液加水稀释,得到稀释反应液;Diluting the reductive amination reaction solution with water to obtain a diluted reaction solution;
将所述稀释反应液和有机萃取剂混合萃取,得到萃取有机相;Mixing and extracting the diluted reaction solution and an organic extractant to obtain an extracted organic phase;
将所述萃取有机相依次进行洗涤、干燥、去除有机溶剂和柱层析,得到式I所示结构的6PPD代谢物。The extracted organic phase is washed, dried, organic solvent removed and column chromatographed sequentially to obtain the 6PPD metabolite with the structure shown in formula I.
优选的,所述有机萃取剂为乙酸乙酯。Preferably, the organic extractant is ethyl acetate.
优选的,所述柱层析分离纯化时使用的洗脱剂为乙酸乙酯和石油醚的混合溶剂,所述乙酸乙酯和石油醚的体积比为1:4。Preferably, the eluent used in the column chromatography separation and purification is a mixed solvent of ethyl acetate and petroleum ether, and the volume ratio of ethyl acetate and petroleum ether is 1:4.
优选的,所述柱层析为快速柱层析。Preferably, the column chromatography is flash column chromatography.
本发明提供了一种6PPD代谢物的制备方法,包括以下步骤:将4-氨基二苯胺、二丙酮醇、有机溶剂和氢化试剂混合进行还原胺化反应,得到所述6PPD代谢物的制备方法。本发明提供的制备方法以4-氨基二苯胺、二丙酮醇和氢化试剂为原料,通过合理设计反应合成路线:在不需要催化剂的条件下,通过一步法进行还原胺化反应,实现了式I所示结构的6PPD代谢物的成功制备,且得率高,可为6PPD的代谢机理研究提供对照品,可用于研究该药物在环境中的代谢过程,对6PPD及其代谢物的系统性研究及风险评估具有极大的价值。同时,本发明提供的制备方法制备成本低、可操作性强,安全系数高,可实现工业化生产式I所示结构的6PPD代谢物。The invention provides a method for preparing 6PPD metabolites, comprising the following steps: mixing 4-aminodiphenylamine, diacetone alcohol, an organic solvent and a hydrogenation reagent for reductive amination reaction to obtain the 6PPD metabolites. The preparation method provided by the present invention uses 4-aminodiphenylamine, diacetone alcohol and hydrogenation reagent as raw materials, and through rational design of the reaction synthesis route: under the condition of no catalyst, the reductive amination reaction is carried out in one step, and the formula I is realized. The successful preparation of 6PPD metabolites with the indicated structure, and the yield is high, can provide reference substances for the study of the metabolic mechanism of 6PPD, and can be used to study the metabolic process of the drug in the environment, systematic research and risk of 6PPD and its metabolites Evaluations are of great value. At the same time, the preparation method provided by the present invention has low preparation cost, strong operability and high safety factor, and can realize the industrial production of the 6PPD metabolite with the structure shown in formula I.
进一步的,所述还原胺化反应直接得到还原胺化反应液,还包括以下步骤:将所述还原胺化反应液加水稀释,得到稀释反应液;将所述稀释反应液和有机萃取剂混合萃取,得到萃取有机相;将所述萃取有机相依次进行洗涤、干燥、去除有机溶剂和柱层析,得到式I所示结构的6PPD代谢物。本发明通过对还原胺化反应液进行萃取和柱层析分离纯化,能够进一步提高式I所示结构的6PPD代谢物的纯度,为6PPD的代谢机理研究提供高纯度对照品。由实施例的结果表明,本发明制备得到的式I所示结构的6PPD代谢物纯度≥99%。Further, the reductive amination reaction directly obtains a reductive amination reaction solution, further comprising the following steps: diluting the reductive amination reaction solution with water to obtain a diluted reaction solution; mixing the diluted reaction solution and an organic extractant to extract , to obtain the extracted organic phase; the extracted organic phase was washed, dried, removed the organic solvent and column chromatography in sequence to obtain the 6PPD metabolite of the structure shown in formula I. The present invention can further improve the purity of the 6PPD metabolite with the structure shown in formula I by extracting the reductive amination reaction solution and separating and purifying it by column chromatography, so as to provide a high-purity reference substance for the research on the metabolic mechanism of 6PPD. The results of the examples show that the purity of the 6PPD metabolite with the structure shown in formula I prepared by the present invention is ≥99%.
附图说明Description of drawings
图1为本发明实施例提供的式I所示结构的6PPD代谢物的合成路线图。Fig. 1 is a synthetic route diagram of the 6PPD metabolite with the structure shown in formula I provided by the embodiment of the present invention.
具体实施方式detailed description
本发明提供了一种6PPD代谢物的制备方法,包括以下步骤:The present invention provides a kind of preparation method of 6PPD metabolite, comprises the following steps:
将4-氨基二苯胺、二丙酮醇、有机溶剂和氢化试剂混合进行还原胺化反应,得到式I所示结构的6PPD代谢物;4-aminodiphenylamine, diacetone alcohol, an organic solvent and a hydrogenation reagent are mixed for reductive amination reaction to obtain the 6PPD metabolite of the structure shown in formula I;
在本发明中,若无特殊说明,所有制备原料/组分均为本领域技术人员熟知的市售产品。In the present invention, unless otherwise specified, all preparation raw materials/components are commercially available products well known to those skilled in the art.
在本发明中,所述4-氨基二苯胺的结构式如式II所示:In the present invention, the structural formula of the 4-aminodiphenylamine is shown in formula II:
在本发明中,所述氢化试剂优选包括硼氢化钠、氰基硼氢化钠和三乙酰氧基硼氢化钠中的一种或多种,更优选为氰基硼氢化钠。In the present invention, the hydrogenation reagent preferably includes one or more of sodium borohydride, sodium cyanoborohydride and sodium triacetoxyborohydride, more preferably sodium cyanoborohydride.
在本发明中,所述有机溶剂优选包括四氢呋喃、甲醇或二氯甲烷,更优选为甲醇。In the present invention, the organic solvent preferably includes tetrahydrofuran, methanol or dichloromethane, more preferably methanol.
在本发明中,所述氢化试剂和所述4-氨基二苯胺的摩尔比优选为(1~2):1,更优选为1.5:1。In the present invention, the molar ratio of the hydrogenation reagent to the 4-aminodiphenylamine is preferably (1-2):1, more preferably 1.5:1.
在本发明中,所述二丙酮醇和所述4-氨基二苯胺的摩尔比优选为(1~2):1,更优选为1.1:1。In the present invention, the molar ratio of the diacetone alcohol to the 4-aminodiphenylamine is preferably (1-2):1, more preferably 1.1:1.
本发明对所述有机溶剂的用量没有特殊要求,能够确保所述还原胺化反应的原料完全溶解、所述还原胺化反应顺利进行即可。The present invention has no special requirements on the amount of the organic solvent, as long as the raw materials of the reductive amination reaction are completely dissolved and the reductive amination reaction proceeds smoothly.
在本发明中,所述还原胺化反应的温度优选为10~40℃,更优选为25℃。In the present invention, the temperature of the reductive amination reaction is preferably 10-40°C, more preferably 25°C.
在本发明中,所述还原胺反应的保温时间优选为8~24h,更优选为12h。In the present invention, the holding time of the reducing amine reaction is preferably 8-24 hours, more preferably 12 hours.
在本发明中,所述还原胺化反应直接得到还原胺化反应液,本发明优选还包括以下步骤:In the present invention, the reductive amination reaction directly obtains the reductive amination reaction solution, and the present invention preferably further includes the following steps:
将所述还原胺化反应液加水稀释,得到稀释反应液;Diluting the reductive amination reaction solution with water to obtain a diluted reaction solution;
将所述稀释反应液和有机萃取剂混合萃取,得到萃取有机相;Mixing and extracting the diluted reaction solution and an organic extractant to obtain an extracted organic phase;
将所述萃取有机相依次进行洗涤、干燥、去除有机溶剂和柱层析,得到式I所示结构的6PPD代谢物。The extracted organic phase is washed, dried, organic solvent removed and column chromatographed sequentially to obtain the 6PPD metabolite with the structure shown in formula I.
在本发明中,所述稀释用水的体积与所述有机溶剂的体积之比优选为1:4。In the present invention, the ratio of the volume of the dilution water to the volume of the organic solvent is preferably 1:4.
在本发明中,所述有机萃取剂优选为乙酸乙酯。所述萃取的次数优选为3次,每次萃取时所述乙酸乙酯的体积与所述有机溶剂的体积之比优选为1:1。本发明合并每次获得的萃取有机相,得到萃取有机相。In the present invention, the organic extractant is preferably ethyl acetate. The number of extractions is preferably 3 times, and the ratio of the volume of ethyl acetate to the volume of the organic solvent during each extraction is preferably 1:1. In the present invention, the extracted organic phases obtained each time are combined to obtain the extracted organic phase.
本发明中,所述洗涤优选采用饱和食盐水洗。In the present invention, the washing is preferably washed with saturated brine.
在本发明中,所述干燥优选采用无水硫酸钠干燥。In the present invention, the drying is preferably performed using anhydrous sodium sulfate.
在本发明中,所述去除有机溶剂的具体实施方式优选为减压蒸馏,本发明对所述减压蒸馏的具体实施过程没有特殊要求。In the present invention, the specific implementation of the removal of the organic solvent is preferably vacuum distillation, and the present invention has no special requirements for the specific implementation process of the vacuum distillation.
本发明优选对所述去除有机溶剂的残余物进行柱层析。In the present invention, column chromatography is preferably performed on the residue from the removal of the organic solvent.
在本发明中,所述柱层析时使用的洗脱剂优选为乙酸乙酯和石油醚的混合溶剂,所述乙酸乙酯和石油醚的体积比优选为1:4。在本发明中,所述柱层析优选为快速柱层析。In the present invention, the eluent used in the column chromatography is preferably a mixed solvent of ethyl acetate and petroleum ether, and the volume ratio of ethyl acetate and petroleum ether is preferably 1:4. In the present invention, the column chromatography is preferably flash column chromatography.
本发明优选将所述柱层析得到的洗脱液干燥后,得到所述式I所示结构的6PPD代谢物。In the present invention, the eluate obtained by the column chromatography is preferably dried to obtain the 6PPD metabolite with the structure shown in formula I.
在本发明中,式I所示结构的6PPD代谢物为红色油状液体。In the present invention, the 6PPD metabolite with the structure shown in formula I is a red oily liquid.
为了进一步说明本发明,下面结合附图和实施例对本发明提供的技术方案进行详细地描述,但不能将它们理解为对本发明保护范围的限定。In order to further illustrate the present invention, the technical solutions provided by the present invention will be described in detail below in conjunction with the accompanying drawings and examples, but they should not be construed as limiting the protection scope of the present invention.
实施例1Example 1
按照图1所示的流程图制备式I所示结构的6PPD代谢物:According to the flow chart shown in Figure 1, prepare the 6PPD metabolite of structure shown in formula I:
将4-氨基二苯胺(1.84g,10.00mmol)和二丙酮醇(1.28g,11.00mmol)溶于甲醇(20mL)后,加入氰基硼氢化钠(0.94g,15.00mmol),25℃反应12小时h。反应完毕后加水(5mL)稀释,乙酸乙酯(20mL×3)萃取,饱和食盐水洗,无水硫酸钠干燥后,减压蒸除溶剂,残余物用flash柱层析分离纯化(v:v=1:4,乙酸乙酯/石油醚),得到红色油状液体为式I所示结构的6PPD代谢物,即:2-甲基-4-((4-(苯基氨基)苯基)氨基)戊烷-2-醇,2.07g,收率73%)。1H NMR(600MHz,Chloroform-d)δ7.25–7.17(m,2H),7.08–6.97(m,2H),6.95–6.87(m,2H),6.85–6.79(m,1H),6.79–6.66(m,2H),3.90–3.72(m,1H),1.73–1.63(m,2H),1.35(s,3H),1.27(s,3H),1.16(d,J=6.2Hz,3H).HRMS(ESI)C18H25N2O+[M+H]+计算值:285.1961,实测值:285.1967.HPLC:99.72%(λ=280nm,tR=12.18min).After dissolving 4-aminodiphenylamine (1.84g, 10.00mmol) and diacetone alcohol (1.28g, 11.00mmol) in methanol (20mL), add sodium cyanoborohydride (0.94g, 15.00mmol), and react at 25°C for 12 hour h. After the reaction was completed, it was diluted with water (5 mL), extracted with ethyl acetate (20 mL×3), washed with saturated brine, dried over anhydrous sodium sulfate, and evaporated to remove the solvent under reduced pressure, and the residue was separated and purified by flash column chromatography (v:v= 1:4, ethyl acetate/petroleum ether), the red oily liquid obtained is the 6PPD metabolite of the structure shown in formula I, namely: 2-methyl-4-((4-(phenylamino)phenyl)amino) Pentan-2-ol, 2.07 g, 73% yield). 1 H NMR (600MHz, Chloroform-d) δ7.25–7.17(m,2H),7.08–6.97(m,2H),6.95–6.87(m,2H),6.85–6.79(m,1H),6.79– 6.66(m,2H),3.90–3.72(m,1H),1.73–1.63(m,2H),1.35(s,3H),1.27(s,3H),1.16(d,J=6.2Hz,3H) .HRMS(ESI)C 18 H 25 N 2 O + [M+H] + calculated value: 285.1961, measured value: 285.1967. HPLC: 99.72% (λ = 280nm, t R = 12.18min).
实施例2Example 2
按照图1所示的流程图制备式I所示结构的6PPD代谢物:According to the flow chart shown in Figure 1, prepare the 6PPD metabolite of structure shown in formula I:
将4-氨基二苯胺VIII(1.84g,10.00mmol)和二丙酮醇(1.16g,10.00mmol)溶于四氢呋喃(20mL)后,加入硼氢化钠(0.38g,10.00mmol),10℃反应24小时。反应完毕后加水(5mL)稀释,乙酸乙酯(20mL×3)萃取,饱和食盐水洗,无水硫酸钠干燥后,减压蒸除溶剂,残余物用flash柱层析分离纯化(1:4乙酸乙酯/石油醚),得到红色油状液体为式I所示结构的6PPD代谢物,即:2-甲基-4-((4-(苯基氨基)苯基)氨基)戊烷-2-醇,1.56g,收率55%)。After dissolving 4-aminodiphenylamine VIII (1.84g, 10.00mmol) and diacetone alcohol (1.16g, 10.00mmol) in tetrahydrofuran (20mL), add sodium borohydride (0.38g, 10.00mmol) and react at 10°C for 24 hours . After the reaction was completed, it was diluted with water (5mL), extracted with ethyl acetate (20mL×3), washed with saturated brine, dried over anhydrous sodium sulfate, evaporated to remove the solvent under reduced pressure, and the residue was separated and purified by flash column chromatography (1:4 acetic acid ethyl ester/petroleum ether), the red oily liquid obtained is the 6PPD metabolite of the structure shown in formula I, namely: 2-methyl-4-((4-(phenylamino)phenyl)amino)pentane-2- Alcohol, 1.56g, yield 55%).
实施例3Example 3
按照图1所示的流程图制备式I所示结构的6PPD代谢物:将4-氨基二苯胺VIII(1.84g,10.00mmol)和二丙酮醇(2.32g,20.00mmol)溶于二氯甲烷(20mL)后,加入三乙酰氧基硼氢化钠(4.24g,20.00mmol),40℃反应8小时。反应完毕后加水(5mL)稀释,乙酸乙酯(20mL×3)萃取,饱和食盐水洗,无水硫酸钠干燥后,减压蒸除溶剂,残余物用flash柱层析分离纯化(1:4乙酸乙酯/石油醚),得到红色油状液体为式I所示结构的6PPD代谢物,即:2-甲基-4-((4-(苯基氨基)苯基)氨基)戊烷-2-醇,1.19g,收率42%)。The 6PPD metabolite of the structure shown in formula I is prepared according to the flowchart shown in Figure 1: 4-aminodiphenylamine VIII (1.84g, 10.00mmol) and diacetone alcohol (2.32g, 20.00mmol) are dissolved in dichloromethane ( After 20 mL), sodium triacetoxyborohydride (4.24 g, 20.00 mmol) was added and reacted at 40°C for 8 hours. After the reaction was completed, it was diluted with water (5mL), extracted with ethyl acetate (20mL×3), washed with saturated brine, dried over anhydrous sodium sulfate, evaporated to remove the solvent under reduced pressure, and the residue was separated and purified by flash column chromatography (1:4 acetic acid ethyl ester/petroleum ether), the red oily liquid obtained is the 6PPD metabolite of the structure shown in formula I, namely: 2-methyl-4-((4-(phenylamino)phenyl)amino)pentane-2- Alcohol, 1.19g, yield 42%).
综上,本发明提供的式I所示结构的6PPD代谢物的制备方法,设计合理,可操作性强,得率高,可实现工业化生产。且本发明制备得到的式I所示结构的6PPD代谢物纯度≥99%,可为6PPD的代谢机理研究提供高纯度对照品,可用于研究该药物在环境中的代谢过程,对6PPD及其代谢物的系统性研究及风险评估具有极大的价值。同时,本发明提供的制备方法制备成本低、可操作性强,安全系数高,可实现工业化生产式I所示结构的6PPD代谢物。In conclusion, the preparation method of the 6PPD metabolite with the structure shown in formula I provided by the present invention is reasonable in design, strong in operability and high in yield, and can realize industrial production. And the purity of the 6PPD metabolite of the structure shown in formula I prepared by the present invention is more than or equal to 99%, which can provide a high-purity reference substance for the research on the metabolic mechanism of 6PPD, and can be used to study the metabolic process of the drug in the environment. Systematic research and risk assessment of pesticides are of great value. At the same time, the preparation method provided by the present invention has low preparation cost, strong operability and high safety factor, and can realize the industrial production of the 6PPD metabolite with the structure shown in formula I.
尽管上述实施例对本发明做出了详尽的描述,但它仅仅是本发明一部分实施例,而不是全部实施例,还可以根据本实施例在不经创造性前提下获得其他实施例,这些实施例都属于本发明保护范围。Although the foregoing embodiment has described the present invention in detail, it is only a part of the embodiments of the present invention, rather than all embodiments, and other embodiments can also be obtained according to the present embodiment without inventive step, and these embodiments are all Belong to the protection scope of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211129168.3A CN115466185A (en) | 2022-09-16 | 2022-09-16 | A kind of preparation method of 6PPD metabolite |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211129168.3A CN115466185A (en) | 2022-09-16 | 2022-09-16 | A kind of preparation method of 6PPD metabolite |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115466185A true CN115466185A (en) | 2022-12-13 |
Family
ID=84333522
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211129168.3A Pending CN115466185A (en) | 2022-09-16 | 2022-09-16 | A kind of preparation method of 6PPD metabolite |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115466185A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3388096A (en) * | 1964-09-21 | 1968-06-11 | Firestone Tire & Rubber Co | Nu-2-(4-hydroxy-4-methylpentyl)-nu'-phenyl-para-phenylenediamine |
US3424713A (en) * | 1966-02-21 | 1969-01-28 | Firestone Tire & Rubber Co | Rubber stabilized with a mixture of p-phenylenediamines |
US20060258887A1 (en) * | 2005-05-16 | 2006-11-16 | Korea Kumho Petrochemical Co., Ltd. | Method for preparing 4-aminodiphenylamine |
WO2021003295A1 (en) * | 2019-07-02 | 2021-01-07 | Regeneron Pharmaceuticals, Inc. | Modulators of hsd17b13 and methods of use thereof |
CN114054057A (en) * | 2021-10-26 | 2022-02-18 | 中石化南京化工研究院有限公司 | Preparation method and evaluation method of catalyst for synthesizing age resister 6PPD (p-phenylene sulfide) sulfide precious metal |
-
2022
- 2022-09-16 CN CN202211129168.3A patent/CN115466185A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3388096A (en) * | 1964-09-21 | 1968-06-11 | Firestone Tire & Rubber Co | Nu-2-(4-hydroxy-4-methylpentyl)-nu'-phenyl-para-phenylenediamine |
US3424713A (en) * | 1966-02-21 | 1969-01-28 | Firestone Tire & Rubber Co | Rubber stabilized with a mixture of p-phenylenediamines |
US20060258887A1 (en) * | 2005-05-16 | 2006-11-16 | Korea Kumho Petrochemical Co., Ltd. | Method for preparing 4-aminodiphenylamine |
WO2021003295A1 (en) * | 2019-07-02 | 2021-01-07 | Regeneron Pharmaceuticals, Inc. | Modulators of hsd17b13 and methods of use thereof |
CN114054057A (en) * | 2021-10-26 | 2022-02-18 | 中石化南京化工研究院有限公司 | Preparation method and evaluation method of catalyst for synthesizing age resister 6PPD (p-phenylene sulfide) sulfide precious metal |
Non-Patent Citations (2)
Title |
---|
A. E. OBERSTER ET AL.: "Syntheses of novel substituted p-phenylenediamines", 《CANADIAN JOURNAL OF CHEMISTRY》, vol. 45, no. 3, pages 195 - 201 * |
吴结华: "新型橡胶防老剂6PPD合成催化剂", 《工业催化》, vol. 20, no. 7, pages 43 - 45 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106068121A (en) | Single solvent is used to carry out clomiphene synthesis | |
CN115466185A (en) | A kind of preparation method of 6PPD metabolite | |
CN118852058A (en) | A preparation method of vortioxetine metabolite | |
CN110156652A (en) | A kind of preparation method of geraniol thioacetate | |
CN110818587B (en) | Preparation method of ketamine and synthesis method of intermediate compound | |
CN116199618A (en) | Method for synthesizing haloperidol impurity E with high yield and high purity | |
CN116082212A (en) | Dipyrrole compound and preparation method thereof | |
CN109534979B (en) | Separation and purification method and production method of 6-gingerol | |
CN111116655B (en) | Preparation method of high-optical-purity tenofovir benzyl ester phosphonamide prodrug | |
CN107089942B (en) | The preparation method of tegafur, gimeracil and oteracil potassium impurity B CB | |
CN110551141B (en) | Process for the preparation of compounds | |
CN107935869A (en) | Butanedioic acid desmethylvenlafaxine impurity and its preparation method and application | |
CN110963945A (en) | Preparation, separation and purification method of cinacalcet intermediate impurity | |
CN101302239B (en) | Synthetic method of telbivudine and intermediate thereof | |
EP3666756A1 (en) | Method for preparing levetiracetam | |
CN104119381A (en) | Preparation method of fotemustine | |
CN116396236A (en) | Diaryl methyl sulfonamide compound and preparation method thereof | |
CN117326959A (en) | An aminoether compound and its synthesis method | |
CN111349012B (en) | Preparation method of halogenated aromatic compound and intermediate thereof | |
CN116606238A (en) | A kind of N-Boc-3-nitroindole and preparation method thereof | |
CN119285626A (en) | Preparation method and application of antiemetic compound | |
CN118908875A (en) | 1-Methyl-2-nitro-3- (1, 4-naphthoquinone-2-yl) indole and preparation method thereof | |
CN108101880A (en) | Method that is a kind of while preparing oxo Rhodamine Derivatives and thiorhodamine derivative | |
CN118359506A (en) | A method for synthesizing stable isotope-labeled N-methylbenzylamine | |
CN115160153A (en) | L-menthylamine, D-neomenthamine and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20221213 |
|
RJ01 | Rejection of invention patent application after publication |